drugset / Trial / NCT02234544

Effect of an Inhibitor of Cholesterol Absorption on Vitamin D Levels

NCT02234544

Phase 4 Completed 52 enrolled Federal University of Rio Grande do Sul
RandomizedFactorialQuadruple-blindBasic science

Summary

Double-blind randomized controlled trial to evaluate the serum levels of 25(OH)D after a single oral dose of cholecalciferol 50,000 IU plus ezetimibe or placebo. Differences between the serum levels of 25(OH)D in response to cholecalciferol plus ezetimibe compared to cholecalciferol plus placebo.

Timeline

Start
2014-10
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 50000 iu Oral
Comparator Ezetimibe Unknown 10 mg

Indications